Company: INSP
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001609550-25-000032
Chunk: 42

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 42
---
, and for the six-month periods ended June 30, 2025 and 2024, stock-based compensation expense was $72.8 million and $58.6 million, respectively, and is included within the segment expense captions of cost of goods sold, research and development expense, and SG&A expense. Revenue by geographic region is as follows: Three Months EndedSix Months EndedJune 30,June 30,2025202420252024United States$207,150 $187,808 $400,756 $343,579 All other countries9,936 8,077 17,647 16,316 Total revenue$217,086 $195,885 $418,403 $359,895 

26

Table of ContentsINSPIRE MEDICAL SYSTEMS, INC. NOTES TO CONDENSED FINANCIAL STATEMENTS (Unaudited) (Table amounts in thousands, except share and per share amounts)

Long-lived tangible assets by geographic location were as follows:June 30, 2025December 31, 2024United States$84,397 $71,008 All other countries877 917 Total long-lived tangible assets$85,274 $71,925 

9. Income (Loss) Per Share

Basic net income (loss) per share is computed by dividing the net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted average number of shares of common stock and dilutive potential shares of common stock outstanding during the period. For the periods presented with a net loss, diluted net loss per share is the same as basic net loss per share as all of the following potentially dilutive shares were antidilutive in those periods.The components of net income (loss) per share are as follows:Three Months EndedSix Months EndedJune 30,June 30,2025202420252024Numerator:Net income (loss)$(3,592)$9,793 $(600)$(212)Denominator:Weighted average number of common shares outstanding — basic29,506,807 29,728,849 29,604,043 29,672,006 Dilutive effect of stock options— 633,661 — — Dilutive effect of restricted stock units— 45,929 —